Third Wave Technologies Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Third Wave Technologies Inc.
TED Talk: Viridian’s Early Data Indicate Strong Competitor To Horizon’s Tepezza
Viridian says Phase I/II data for its thyroid eye disease candidate outperforms Horizon’s Tepezza on multiple measures. Company plans quick advancement into Phase III for VRDN-001.
Execs On The Move, November 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Epigenomics, RainDance, and Brightree name new leadership, and more personnel news from around the industry.
Medtech Execs On The Move, December 2015
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.